Abstract
2-Hydroxypropyl-β-cyclodextrin (cyclodextrin), cyclodextrin-solubilized oleate, and cyclodextrin-solubilized cholesterol were used to modulate proteolysis and secretion of newly-synthesized apolipoprotein B-100 (apoB) in HepG2 cells. Following cyclodextrin and lipid treatments, cells were pulse-labeled with [3H] leucine, and quantitative immunoprecipitation was used to measure apoB synthesis, apoB secreted into the medium, and the cellular content of undegraded apoB that was not secreted. Three-hour treatment with cyclodextrin-solubilized oleate (0.2 mM) increased secreted apoB from 4% (control cells) to 32% and cellular undegraded apoB from 15% (control cells) to 64% of apoB synthesized, which is consistent with earlier studies using bovine serum albumin to complex exogenous oleate. Prolonged daily (4 d or more) administration of 0.5% (3.5 mM) cyclodextrin with medium containing 10% fetal bovine serum increased the secretion of nascent apoB from 5–10% (control) to 17–28% and cellular undegraded apoB from 15–20% (control) to 25–31% of apoB synthesized, respectively. Subsequent administration of cyclodextrin-solubilized cholesterol (10–40 μg) for only 3 h reversed the cyclodextrin-mediated increase in apoB secretion. The application of 0.5% cyclodextrin to HepG2 cells can rapidly (within minutes) stimulate cholesterol efflux, and transiently (over a 1–2 d period) increase cholesterol synthesis. In the current studies, the cyclodextrin-mediated increase in cholesterol synthesis was not concurrent with the increase in apoB secretion. However, prolonged (15 d) administration of cyclodextrin was shown to increase the cellular free cholesterol concentration by 25–41%, reduce the cellular triglyceride concentration by 59% and increase apoB secretion 3- to 4-fold, without affecting the cellular cholesteryl ester concentration. In comparison, 14-d treatment with cyclodextrin-solubilized cholesterol (20 μg/mL) followed by 1-d equilibration without cholesterol was shown to increase the cellular free cholesterol and cholesteryl ester concentrations by 76% and 10-fold, respectively, although apoB secretion was not affected. It is hypothesized that chronic daily administration of 0.5% cyclodextrin increased the cellular cholesterol concentration and flux in discrete putative regulatory compartment which “shielded” nascent apoB from rapid proteolysis and facilitated apoB secretion. In conclusion, cyclodextrin was used independently and in combination with cholesterol or oleate to modulate apoB proteolysis and secretion. We speculate that subcellular changes in cholesterol concentration and flux may modulate apoB production in HepG2 cells.
Similar content being viewed by others
Abbreviations
- ACAT:
-
acyl-CoA: cholesterol acyltransferase
- apoB:
-
apolipoprotein B-100
- BSA:
-
bovine serum albumin
- cyclodextrin or CD:
-
2-hydroxypropyl-β-cyclodextrin
- CH:
-
cholesterol
- ER:
-
endoplasmic retioulum
- FBS:
-
fetal bovine serum
- HDL:
-
high density lipoprotein
- HMG-CoA:
-
β-hydroxy-β-methylglutaryl CoA
- LDL:
-
low density lipoprotein
- MTP:
-
microsomal triglyceride transfer protein
- OA:
-
oleate
- PBS:
-
phosphate-buffered saline
- VLDL:
-
very low density lipoprotein
References
Deckelbaum, R.J., Ramakrishnan, R., Eisenberg, S., Olivecrona, T. and Bengtsson-Olivecrona, G. (1992) Triacylglycerol and Phospholipid Hydrolysis in Human Plasma Lipoproteins: Role of Lipoprotein and Hepatic Lipase, Biochemistry 31, 8544–8551.
Olivecrona, T., Bengtsson-Olivecrona, G., Ostergaard, P., Liu, G., Chevreuil, O., and Hultin, M. (1993) New Aspects on Heparin and Lipoprotein Metabolism, Haemostasis 23 (suppl. 1), 150–160.
Inkeles, S., and Eisenberg, D. (1981) Hyperlipidemia and Coronary Atherosclerosis: A Review, Medicine 60 (2), 110–123.
Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial Results. 1. Reduction in Incidence of Coronary Heart Disease, JAMA 251, 351–364.
Grundy, S.M. (1991) Multifactorial Etiology of Hypercholesterolemia. Implications for Prevention of Coronary Heart Disease, Arterioscler. Thromb. 11, 1619–1635.
Teng, B., Sniderman, A.D., Soutar, A.K., and Thompson, G.R. (1986) Metabolic Basis of Hyperapobetalipoproteinemia. Turnover of Apolipoprotein B in Low Density Lipoprotein and its Precursors and Subfractions Compared with Normal and Familial Hypercholesterolemia, J. Clin. Invest. 77, 663–672.
Arad, Y., Ramakrishnan, R., and Ginsberg, H.N. (1990) Lovastatin Therapy Reduces Low Density Lipoprotein ApoB Levels in Subjects with Combined Hyperlipidemia by Reducing the Production of ApoB-Containing Lipoproteins: Implications for the Pathophysiology of ApoB Production, J. Lipid Res. 31, 567–582.
Vega, G.L., Denke, M.A., and Grundy, S.M. (1991) Metabolic Basis of Primary Hypercholesterolemia, Circulation 84, 118–128.
Sniderman, A.D., Brown, B.G., Stewart, F.F., and Cianflone, K. (1992) From Familial Combined Hyperlipidemia to HyperapoB: Unraveling Overproduction of Hepatic ApoB Lipoproteins, Curr. Opin. Lipidol. 3, 137–142.
Venkatesan, S., Cullen, P., Pacy, P., Halliday, D., and Scott, J. (1993) Stable Isotopes Show a Direct Relation Between VLDL ApoB Overproduction and Serum Triglyceride Levels and Indicate a Metabolically and Biochemically Coherent Basis for Familial Combined Hyperlipidemia, Arterioscler. Thromb. 13, 1110–1118.
Cummings, M.H., Watts, G.F., Pal, C., Umpleby, M., Hennessy, T.R., Naoumova, R., and Sonksen, P.H. (1995) Increased Hepatic Secretion of Very-low-density Lipoprotein Apolipoprotein B-100 in Obesity: A Stable Isotope Study, Clin. Sci. 88, 225–233.
Cummings, M.H., Watts, G.F., Umpleby, M., Hennessy, T.R., Naoumova, R., Slavin, B.M., Thompson, G.R., and Sonksen, P.H. (1995) Increased Hepatic Secretion of Very-Low-Density Lipoprotein Apolipoprotein B-100 in NIDDM, Diabetologia 38, 959–967.
Knott, T.J., Rall, S.C., Jr., Innerarity, T.L., Jacobson, S.F., Urdea, M.S., Levy-Wilson, B., Powell, L.M., Pease, R.J., Eddy, R., Nakai, H., Byers, M., Priestley, L.M., Robertson, E., Rall, L.B., Betsholtz, C., Shows, T.B., Mahley, R.W., and Scott, J. (1985) Human Apolipoprotein B: Structure of Carboxyl-Terminal Domains, Sites of Gene Expression, and Chromosomal Localization, Science 230, 37–43.
Knott, T.J., Pease, R.J., Powell, L.M., Wallis, S.C., Rall, S.C., Jr., Innerarity, T.L., Blackhart, B., Taylor, W.H., Marcel, Y., Milne, R., Johnson, D., Fuller, M., Lusis, A.J., McCarthy, B.J., Mahley, R.H., Levy-Wilson, B., and Scott, J. (1986) Complete Protein Sequence and Identification of Structural Domains of Human Apolipoprotein B, Nature 323, 734–738.
Law, S.W., Grant, S.M., Higuchi, K., Hospattankar, A., Lackner K., Lee, N., and Brewer, H.B., Jr. (1986) Human Liver Apolipoprotein B-100 cDNA: Complete Nucleic Acid and Derived Amino Acid Sequence, Proc. Natl Acad. Sci. USA 83, 8142–8146.
Boström, K., Borén, J., Wettesten, M., Sjöberg, A., Bondjers, G., Wiklund, O., Carlsson, P., and Olofsson, S.-O. (1988) Studies on the Assembly of ApoB-100-Containing Lipoproteins in HepG2 Cells, J. Biol. Chem. 263, 4434–4442.
Borén, J., White, A., Wettesten, M., Scott, J., Graham, L., and Olofsson, S.-O. (1991) The Molecular Mechanism for the Assembly and Secretion of ApoB-100-Containing Lipoproteins, Prog. Lipid Res. 30, 205–218.
Pease, R.J., Harrison, G.B., and Scott, J. (1991) Cotranslational Insertion of Apolipoprotein B into the Inner Leaflet of the Endoplasmic Reticulum, Nature 353, 448–450.
Borén, J., Graham, L., Wettesten, M., Scott, J., White, A., and Olofsson, S.-O. (1992) The Assembly and Secretion of ApoB 100-Containing Lipoproteins in HepG2 Cells. ApoB is Cotranslationally Integrated into Lipoproteins, J. Biol. Chem. 267, 9858–9867.
Wilkinson, J., Higgins, J.A., Groot, P., Gherardi, E., and Bowyer, D. (1993) Topography of Apolipoprotein B in Subcellular Fractions of Rabbit Liver Probed with a Panel of Monoclonal Antibodies, J. Lipid Res. 34, 815–825.
Salam, W.H., Wilcox, H.G., and Heimberg, M. (1988) Effects of Oleic Acid on the Biosynthesis of Lipoprotein Apoproteins and Distribution into the Very-Low-Density Lipoprotein by the Isolated Perfused Rat Liver, Biochem. J. 251, 809–816.
Borén, J., Rustaeus, S., Wettesten, M., Andersson, M., Wiklund, A., and Olofsson, S.-O. (1993) Influence of Triacylglycerol Biosynthesis Rate on the Assembly of ApoB-100-Containing Lipoproteins in Hep G2 Cells, Arterioscler. Thromb. 13, 1743–1754.
Dixon, J.L., and Ginsberg, H.N. (1993) Regulation of Hepatic Secretion of Apolipoprotein B-Containing Lipoproteins: Information Obtained from Cultured Liver Cells, J. Lipid Res. 34, 167–179.
Cianflone, K.M., Yasruel, Z., Rodriguez, M.A., Vas, D., and Sniderman, A.D. (1990) Regulation of ApoB Secretion from HepG2 Cells: Evidence for a Critical Role for Cholesteryl Ester Synthesis in the Response to a Fatty Acid Challenge, J. Lipid Res. 31, 2045–2055.
Tanaka, M., Jingami, H., Otani, H., Cho, M., Ueda, Y., Arai, H., Nagano, Y., Doi, T., Yokode, M., and Kita, T. (1993) Regulation of Apolipoprotein B Production and Secretion in Response to the Change of Intracellular Cholesteryl Ester Contents in Rabbit Hepatocytes, J. Biol. Chem. 268, 12713–12718.
Avramoglu, R.K., Cianflone, K., and Sniderman, A.D. (1995) Role of the Neutral Lipid Accessible Pool in the Regulation of Secretion of ApoB-100 Lipoprotein Particles by HepG2 Cells, J. Lipid Res. 36, 2513–2528.
Musanti, R., Giorgini, L., Lovisolo, P.P., Pirillo, A., Chiari, A., and Ghiselli, G. (1996) Inhibition of Acyl-CoA: Cholesterol Acyltransferase Decreases Apolipoprotein B-100-Containing Lipoprotein Secretion from HepG2 Cells, J. Lipid Res. 37, 1–14.
Thompson, G.R., Naoumova, R.P., and Watts, G.F. (1996) Role of Cholesterol in Regulating Apolipoprotein B Secretion by the Liver, J. Lipid Res. 37, 439–447.
Wu, X., Sakata, N., Lui, E., and Ginsberg, H.N. (1994) Evidence for a Lack of Regulation of the Assembly and Secretion of Apolipoprotein β-Containing Lipoprotein from HepG2 Cells by Cholesteryl Ester, J. Biol. Chem. 269, 12375–12382.
Furukawa, S., and Hirano, T. (1993) Rapid Stimulation of Apolipoprotein B Secretion by Oleate Is Not Associated with Cholesteryl Ester Biosynthesis in HepG2 Cells, Biochim. Biophys. Acta 1170, 32–37.
Borchardt, R.A., and Davis, R.A. (1987) Intrahepatic Assembly of Very Low Density Lipoproteins. Rate of Transport out of the Endoplasmic Reticulum Determines Rate of Secretion, J. Biol. Chem. 262, 16394–16402.
Borén, J., Wettesten, M., Sjöberg, A., Thorlin, T., Bondjers, G., Wiklund, O., and Olofsson, S.-O. (1990) The Assembly and Secretion of ApoB 100 Containing Lipoproteins in HepG2 Cells. Evidence for Different Sites for Protein Synthesis and Lipoprotein Assembly, J. Biol. Chem. 265, 10556–10564.
Furukawa, S., SaKata, N., Ginsberg, H.N., and Dixon, J.L. (1992) Studies of the Sites of Intracellular Degradation of Apolipoprotein B in HepG2 Cells, J. Biol. Chem. 267, 22630–22638.
Sakata, N., Wu, X., Dixon, J.L., and Ginsberg, H.N. (1993) Proteolysis and Lipid-Facilitated Translocation Are Distinct But Competitive Processes That Regulate Secretion of Apolipoprotein B in HepG2 Cells, J. Biol. Chem. 268, 22967–22970.
Sniderman, A.D., and Cianflone, K. (1993) Substrate Delivery as a Determinant of Hepatic ApoB Secretion, Arterioscler. Thormb. 13, 629–636.
Thrift, R.N., Drisko, J., Dueland, S., Trawick, J.D., and Davis, R.A. (1992) Translocation of Apolipoprotein B Across the Endoplasmic Reticulum Is Blocked in a Nonhepatic Cell Line, Proc. Natl. Acad. Sci. USA 89, 9161–9165.
Wetterau, J.L., Aggerbeck, L.P., Bouma, M.E., Eisenberg, C., Munck, A., Hermier, M., Schnutz, J., Gay, G., Rader, D.J., and Gregg, R.E. (1992) Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia, Science 258, 999–1001.
Leiper, J.M., Bayliss, J.D., Pease, R.J., Brett, D.J., Scott, J., and Shoulders, C.C. (1994) Microsomal Triglyceride Transfer Protein, the Abetalipoproteinemia Gene Product, Mediates the Secretion of Apolipoprotein B-Containing Lipoproteins from Heterologous Cells, J. Biol. Chem. 269, 21951–21954.
Gordon, D.A., Jamil, H., Sharp, D., Mullaney, D., Yao, Z., Gregg, R.E., and Wetterau, J. (1994) Secretion of Apolipoprotein B-Containing Lipoproteins from HeLa Cells Is Dependent on Expression of the Microsomal Triglyceride Transfer Protein and Is Regulated by Lipid Availability, Proc. Natl Acad. Sci. USA 91, 7628–7632.
Wetterau, J.R., and Zilversmit, D.B. (1985) Purification and Characterization of Microsomal Triglyceride and Cholesteryl Ester Transfer Protein from Bovine Liver Microsomes, Chem. Phys. Lipids 38, 205–222.
Wu, X., Zhou, M., Huang, L.S., Wetterau, J., and Ginsberg, H.N. (1996) Demonstration of a Physical Interaction Between Microsomal Triglyceride Transfer Protein and Apolipoprotein B During the Assembly of ApoB-Containing Lipoproteins, J. Biol. Chem. 271, 10277–10281.
Wang, S.R., Pessah, M., Infante, J., Catala, D., Salvat, C., and Infante, R. (1988) Lipid and Lipoprotein Metabolism in Hep G2 Cells, Biochim. Biophys. Acta 961, 351–363.
Javitt, N.B. (1990) Hep G2 Cells as a Resource for Metabolic Studies: Lipoprotein, Cholesterol, and Bile Acids, FASEB J. 4, 161–168.
Knowles, B.B., Howe, C.C., and Aden, D.P. (1980) Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface Antigen, Science 209, 497–499.
Dashti, N., Williams, D.L., and Alaupovic, P. (1989) Effects of Oleate and Insulin on the Production Rates and Cellular mRNA Concentrations of Apolipoproteins in HepG2 Cells, J. Lipid Res. 30, 1365–1373.
Pullinger, C.R., North, J.D., Teng, B.-B., Rifici, V.A., Ronhild de Brito, A.E.R., and Scott, J. (1989) The Apolipoprotein B Gene Is Constitutively Expressed in HepG2 Cells: Regulation of Secretion by Oleic Acid, Albumin, and Insulin, and Measurement of the mRNA Half-Life, J. Lipid Res. 30, 1065–1077.
Rash, J.M., Rothblat, G.H., and Sparks, C.E. (1981) Lipoprotein Apolipoprotein Synthesis by Human Hepatoma Cells in Culture, Biochim. Biophys. Acta 666, 294–298.
Thrift, R.N., Forte, T.M., Cahoon, B.E., and Shore, V.G. (1986) Characterization of Lipoproteins Produced by the Human Liver Cell Line, HepG2, Under Defined Conditions J. Lipid Res. 27, 236–250.
Wang, T.W.M., Byrne, C.D., and Hales, C.N. (1994) Effect of Ethanol on Hepatic Apolipoprotein B Synthesis and Secretion in vitro, Biochim. Biophys. Acta 1211, 234–238.
Dashti, N., Franklin, F.A., and Abrahamson, D.R. (1996) Effect of Ethanol on the Synthesis and Secretion of ApoA-I- and ApoB-Containing Lipoproteins in HepG2 Cells, J. Lipid Res. 37, 810–824.
Horikoshi, K. (1979) Production and Industrial Applications of Beta-Cyclodextrin, Process Biochem. 14, 26–30.
Djedaini, F., and Perly, B. (1991) Nuclear Magnetic Resonance Investigation of the Stoichiometries in β-Cyclodextrin: Steroid Inclusion Complexes, J. Pharm. Sci. 80, 1157–1161.
De Caprio, J., Yun, J., and Javitt, N.B. (1992) Bile Acid and Sterol Solubilization in 2-Hydroxypropyl-β-Cyclodextrin, J. Lipid Res. 33, 441–443.
Dixon, J.L., Furukawa, S., and Ginsberg, H.N. (1991) Oleate Stimulates Secretion of Apolipoprotein B-Containing Lipoproteins from HepG2 Cells by Inhibiting Early Intracellular Degradation of Apolipoprotein B, J. Biol. Chem. 266, 5080–5086.
Folch, J., Lees, M., and Sloane-Stanley, G.H. (1957) A Simple Method for the Isolation and Purification of Total Lipides from Animal Tissues, J. Biol. Chem. 226, 497–509.
Bligh, E.G., and Dyer, W.J., (1959) A Rapid Method of Total Lipid Extraction and Purification, Can. J. Biochem. 37, 911–917.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein Measurement with the Folin-Phenol Reagent, J. Biol. Chem. 193, 265–275.
Arrol, S., Mackness, M.I., Laing, I., and Durrington, P.N. (1991) Lipoprotein Secretion by the Human Hepatoma Cell Line HepG2: Differential Rates of Accumulation of Apolipoprotein B and Lipoprotein Lipids in Tissue Culture Media in Response to Albumin, Glucose and Oleate, Biochim. Biophys. Acta 1086, 72–80.
Cianflone, K., Vu, H., Zhang, Z.J., and Sniderman, A.D. (1994) Effects of Albumin on Lipid Synthesis, Apo B-100 Secretion, and LDL Catabolism in HepG2 Cells, Atherosclerosis 107, 125–135.
Watts, G.F., Naoumova, R., Cummings, M.H., Umpleby, A.M., Slavin, B.M., Sonksen, P.H., and Thompson, G.R. (1995) Direct Correlation Between Cholesterol Synthesis and Hepatic Secretion of Apolipoprotein B-100 in Normolipidemic Subjects, Metabolism: Clin. & Exp. 44, 1052–1057.
Benoist, F., and Grand-Perret, T. (1996) ApoB-100 Secretion by HepG2 Cells Is Regulated by the Rate of Triglyceride Biosynthesis But Not by Intracellular Lipid Pools, Arterioscler. Thromb. Vasc. Biol. 16, 1229–1235.
Adeli, K., Wettesten, M., Asp, L., Mohammadi, A., Macri, J., and Olofsson, S.-O. (1997) Intracellular Assembly and Degradation of Apolipoprotein B-100-Containing Lipoproteins in Digitonin-Permeabilized HEP G2 Cells, J. Biol. Chem. 272, 5031–5039.
Spring, D.J., Chen-Liu, L.W., Chatterton, J.E., Elovson, J., and Schumaker, V.N. (1992) Lipoprotein Assembly. Apolipoprotein B Size Determines Lipoprotein Core Circumference, J. Biol. Chem. 267, 14839–14845.
Wang, X., Sato, R., Brown, M.S., Hua, X., and Goldstein, J.L. (1994) SREBP-1, A Membrane-Bound Transcription Factor Released by Sterol-Regulated Proteolysis, Cell 77, 53–62.
Adeli, K., (1994) Regulated Intracellular Degradation of Apolipoprotein B in Semipermeable HepG2 Cells, J. Biol. Chem. 269, 9166–9175.
Kilsdonk, E.P.C., Yancey, P.G., Stoudt, G.W., Bangerter, F.W., Johnson, W.J., Phillips, M.C., and Rothblat, G.H. (1995) Cellular Cholesterol Efflux Mediated by Cyclodextrins, J. Biol. Chem. 270, 17250–17256.
Yancey, P.G., Rodrigueza, W.V., Kilsdonk, E.P.C., Stoudt, G.W., Johnson, W.J., Phillips, M.C., and Rothblat, G.H. (1996) Cellular Cholesterol Efflux Mediated by Cyclodextrins. Demonstration of Kinetic Pools and Mechanisms of Efflux, J. Biol. Chem. 271, 16026–16034.
DeGrella, R.F., and Simoni, R.D. (1982) Intracellular Transport of Cholesterol to the Plasma Membrane, J. Biol. Chem. 257, 14256–14262.
Urbani, L., and Simoni, R.D. (1990) Cholesterol and Vesicular Stomatitis Virus G Protein Take Separate Routes from the Endoplasmic Reticulum to the Plasma Membrane, J. Biol. Chem. 265, 1919–1923.
Winegar, D.A., Salisbury, J.A., Sundseth S.S., and Hawke, R.L. (1996) Effects of Cyclosporin on Cholesterol 27-Hydroxylation and LDL Receptor Activity in HepG2 Cells, J. Lipid Res. 37, 179–191.
Gherardi, E., Thomas, K., Le Cras, T.D., Fitzsimmons, C., Moorby, C.D., and Bowyer, D.E. (1992) Growth Requirements and Expression of LDL Receptor and HMG-CoA Reductase in HepG2 Hepatoblastoma Cells Cultured in a Chemically Defined Medium, J. Cell Sci. 103, 531–539.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Peluso, M.R., Dixon, J.L. Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells. Lipids 32, 811–824 (1997). https://doi.org/10.1007/s11745-997-0104-2
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-997-0104-2